IndraLab
Statements
USP22 inhibits cell population proliferation. 29 / 31
|
20
9
sparser
"A recent study suggested that USP22 could increase TGF-β expression and promote the epithelial–mesenchymal transition (EMT). xref In addition, another study demonstrated that silencing USP22 could inhibit proliferation and induce cell cycle arrest in bladder cancer cells. xref Furthermore, USP22 was also reported with high expression level in different malignancies, such as breast cancer xref and colorectal cancer. xref Thus, these lines of evidence strongly suggested that the oncogenic role of the USP22 might contribute to progression and predict the prognosis and become an attractive therapeutic target in cancers."